Mirtazapine Tablet, Orally Disintegrating
Product Images NDC 57237-013

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 57237-013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label-principal Display Panel (15 mg Blister Carton (5 x 6 Unit-dose))

Package Label-principal Display Panel (15 mg Blister Carton (5 x 6 Unit-dose))
This is a description for Once-A-Day Mirtazapine Orally Disintegrating Tablets, USP. Each tablet contains 15 mg of mirtazapine USP along with crospovidone, mannitol, microcrystalline cellulose, aspartame, strawberry guarana and natural and artificial peppermint flavors, colloidal silicon dioxide, and magnesium stearate. It is child-resistant and should be stored at 20° to 25°C with protection from light and moisture. Tablets can be easily removed from the packaging by tearing the perforation and pushing the tablet through the foil. Usual dosage and prescribing information is enclosed with the medication guide provided.*
FDA Label Image

Package Label-principal Display Panel (30 mg Blister Carton (5 x 6 Unit-dose))

Package Label-principal Display Panel (30 mg Blister Carton (5 x 6 Unit-dose))
This text is a description of medication. The medication is Once-a-day Mirtazapine Oral Disintegrating Tablets, USP. The package contains five blister strips, each containing six unit dose tablets. Each orally disintegrating tablet contains 30 mg of Mirtazapine USP, and several other ingredients. The package has a child-resistant feature and should be stored at 20° to 25°C. The package should be protected from light and moisture, and the tablets should be used immediately upon opening the individual tablet blister. The medication is distributed by Rising Health LLC and manufactured in India. The text also contains instructions for removing the tablets from the blister strip.*
FDA Label Image

Package Label-principal Display Panel (45 mg Blister Carton (5 x 6 Unit-dose))

Package Label-principal Display Panel (45 mg Blister Carton (5 x 6 Unit-dose))
FDA Label Image

Chemical Structure (Mirtazapine Str)

Chemical Structure (Mirtazapine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.